# Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer

> **NCT02129257** · PHASE2 · COMPLETED · sponsor: **Hellenic Cooperative Oncology Group** · enrollment: 73 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** AFLIBERCEPT
- **DRUG:** Irinotecan
- **DRUG:** 5-Fluorouracil
- **DRUG:** Folinic Acid

## Key facts

- **NCT ID:** NCT02129257
- **Lead sponsor:** Hellenic Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-26
- **Primary completion:** 2017-01
- **Final completion:** 2017-09-25
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2017-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02129257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02129257, "Clinical Trial of Combination Chemotherapy With Aflibercept in Patients With Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02129257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*